Technical Analysis for CBIO - Catalyst Inc.

Grade Last Price % Change Price Change
grade D 9.49 -3.65% -0.36
CBIO closed down 3.65 percent on Friday, October 19, 2018, on 61 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Earnings due: Nov 1

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical CBIO trend table...

Date Alert Name Type % Chg
Oct 19 Stochastic Reached Oversold Weakness 0.00%
Oct 19 Below Lower BB Weakness 0.00%
Oct 19 Down 3 Days in a Row Weakness 0.00%
Oct 19 Lower Bollinger Band Touch Weakness 0.00%
Oct 19 Oversold Stochastic Weakness 0.00%
Oct 18 20 DMA Resistance Bearish -3.65%
Oct 18 50 DMA Resistance Bearish -3.65%
Oct 18 Multiple of Ten Bearish Other -3.65%
Oct 18 BB Squeeze Ended Range Expansion -3.65%
Oct 18 Lower Bollinger Band Touch Weakness -3.65%

Older signals for CBIO ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Catalyst Biosciences, Inc., a biopharmaceutical company, focuses on discovering and developing novel biopharmaceutical products based on engineered human proteases. The company designs its proteases to promote hemostasis and to prevent inflammation. Its pipeline of protease therapeutics include CB 813d/PF-05280602, an engineered Factor VIIa drug candidate that completed a Phase 1 clinical trial evaluating safety and tolerability, as well as pharmacokinetics, pharmacodynamics, and coagulation activity. The company's pre-clinical development stage drugs comprise CB 2679d/ISU 304, a next-generation Factor IX drug for the treatment of hemophilia B inhibitor patients; and an engineered Factor Xa for hemophilia and the control of bleeding in non-hemophilia patients. It also develops factor C3 for the prevention of renal delayed graft function and the treatment of dry age-related macular degeneration. Catalyst Biosciences, Inc. is headquartered in South San Francisco, California.
Is CBIO a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 37.0
52 Week Low 4.15
Average Volume 176,378
200-Day Moving Average 18.9434
50-Day Moving Average 10.2928
20-Day Moving Average 10.3275
10-Day Moving Average 10.059
Average True Range 0.4938
ADX 15.69
+DI 14.8941
-DI 26.421
Chandelier Exit (Long, 3 ATRs ) 9.6486
Chandelier Exit (Short, 3 ATRs ) 10.9214
Upper Bollinger Band 11.1138
Lower Bollinger Band 9.5412
Percent B (%b) -0.03
BandWidth 15.227306
MACD Line -0.1247
MACD Signal Line -0.0587
MACD Histogram -0.066
Fundamentals Value
Market Cap 40.89 Million
Num Shares 4.31 Million
EPS -14.07
Price-to-Earnings (P/E) Ratio -0.67
Price-to-Sales 35.66
Price-to-Book 0.66
PEG Ratio 0.03
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 10.20
Resistance 3 (R3) 10.26 10.08 10.08
Resistance 2 (R2) 10.08 9.90 10.05 10.04
Resistance 1 (R1) 9.79 9.79 9.70 9.73 10.00
Pivot Point 9.61 9.61 9.57 9.58 9.61
Support 1 (S1) 9.32 9.43 9.23 9.26 8.98
Support 2 (S2) 9.14 9.32 9.11 8.94
Support 3 (S3) 8.85 9.14 8.90
Support 4 (S4) 8.79